ClassID:

92875

C07C237/24 - CPC Classification

Classification description:

Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton

Sub-classes:
Recent Application in this class:
#1
20250268903
2025-08-28

RXFP1 AGONISTS

#2
20250144078
2025-05-08

THIOSTREPTON-INSPIRED COMPOUNDS FOR TREATMENT OF CANCER AND PREPARATION THEREOF

#3
20250122147
2025-04-17

ARYL CYCLOHEXANEDIONE DERIVATIVE OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAME, AND METHOD FOR USE THEREOF

#4
20250099423
2025-03-27

PIPERAZINE-BASED AGONISTS OF LFA-1 AND VLA-4

#5
20250092024
2025-03-20

SUBSTITUTED CYCLOHEXYL COMPOUNDS AS NOP INHIBITORS

#6
20250049765
2025-02-13

BICYCLO [3.2.0] HEPTANE BIS(AMIDE) RXFP1 AGONISTS

#7
20240360075
2024-10-31

N-SUBSTITUTED C6 CYCLYL CARBOXAMIDE COMPOUNDS AND USES THEREOF

#8
20240173307
2024-05-30

MODULATORS OF THE INTEGRATED STRESS PATHWAY

#9
20230210847
2023-07-06

Substituted Alkynylene Compounds As Anticancer Agents

#10
20230144411
2023-05-11

Substituted cyclohexyl compounds as NOP inhibitors

#11
20220281804
2022-09-08

Cyclic diones as herbicidal compounds

#12
20220081430
2022-03-17

Substituted amide compounds useful as farnesoid X receptor modulators

#13
20220002309
2022-01-06

SSAO INHIBITORS AND USES THEREOF

#14
20210393599
2021-12-23

MODULATORS OF THE INTEGRATED STRESS PATHWAY

#15
20210379055
2021-12-09

Substituted alkynylene compounds as anticancer agents

#16
20210340127
2021-11-04

Substituted cyclohexyl compounds as NOP inhibiiors

#17
20200253901
2020-08-13

STABLE DOSAGE FORMS OF LEVOMILNACIPRAN

#18
20200181104
2020-06-11

SSAO INHIBITORS AND USES THEREOF

#19
20200017488
2020-01-16

Heterocyclic inhibitors of the sodium channel

#20
20190092809
2019-03-28

Neuropeptide S receptor (NPSR) agonists

#21
20180244606
2018-08-30

Farnesoid X receptor agonists and uses thereof

#22
20180237385
2018-08-23

Agonists of protein tyrosine phosphatase SHP-1

#23
20180111894
2018-04-26

Benzimidazole inhibitors of the sodium channel

#24
20180099977
2018-04-12

Inhibitors of histone deacetylase

#25
20180028476
2018-02-01

STABLE DOSAGE FORMS OF LEVOMILNACIPRAN

#26
20180016282
2018-01-18

INHIBITORS OF HISTONE DEACETYLASE

#27
20170267629
2017-09-21

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

#28
20170260130
2017-09-14

Benzimidazole Inhibitors of the Sodium Channel

#29
20170217955
2017-08-03

INHIBITORS OF HISTONE DEACETYLASE

#30
20170208803
2017-07-27

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#31
20170145003
2017-05-25

HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL

#32
20170107203
2017-04-20

HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL

#33
20160347761
2016-12-01

Inhibitors of histone deacetylase

#34
20160318851
2016-11-03

Process for preparing levomilnacipran

#35
20160280632
2016-09-29

Gamma amino acid building blocks

#36
20160264517
2016-09-15

3-aminocyclopentane carboxamide derivatives

#37
20160251351
2016-09-01

Inhibitors of histone deacetylase

#38
20160129122
2016-05-12

FATTY ACID ANTIVIRAL CONJUGATES AND THEIR USES

#39
20160039746
2016-02-11

Pesticidal compositions and processes related thereto

#40
20160037771
2016-02-11

Pesticidal compositions and processes related thereto

#41
20160016939
2016-01-21

Heterocyclic inhibitors of the sodium channel

#42
20150368186
2015-12-24

Lysine specific demethylase-1 inhibitors and their use

#43
20150361032
2015-12-17

Benzimidazole inhibitors of the sodium channel

#44
20150315132
2015-11-05

Aminocyclobutane derivatives, method for preparing same and the use thereof as drugs

#45
20150210635
2015-07-30

Compound having ability to inhibit 11Beta-HSD1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient

#46
20150148523
2015-05-28

Gamma amino acid building blocks

#47
20150119452
2015-04-30

Compositions and methods for the treatment of neurological conditions

#48
20150065508
2015-03-05

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#49
20150051199
2015-02-19

Pharmaceutical compounds

#50
20150038587
2015-02-05

Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide

#51
20140357634
2014-12-04

Substituted 4-aminocyclohexane derivatives

#52
20140213657
2014-07-31

Lysine specific demethylase-1 inhibitors and their use

#53
20140171313
2014-06-19

Pesticidal compositions and processes related thereto

#54
20140171312
2014-06-19

Pesticidal compositions and processes related thereto

#55
20140094613
2014-04-03

PROCESS FOR PRODUCING 3-ALKOXY-2-AMINO-6-FLUOROBICYCLO [3.1.0] HEXANE-2,6-DICARBOXYLIC ACID DERIVATIVE AND INTERMEDIATE THEREOF

#56
20140080802
2014-03-20

Inhibitors of histone deacetylase

#57
20140080800
2014-03-20

Inhibitors of histone deacetylase

#58
20130345254
2013-12-26

CYCLOHEXANE SUBSTITUTED AMINO CYCLOPENTANE DERIVATIVES AS USEFUL CCR2 ANTAGONISTS

#59
20130253063
2013-09-26

STABLE DOSAGE FORMS OF LEVOMILNACIPRAN

#60
20130217660
2013-08-22

Prolylcarboxypeptidase inhibitors

#61
20130210919
2013-08-15

NOVEL CRYSTALLINE FORMS OF (1S,2R)-2-(AMINO METHYL)-N,N-DIETHYL-1-PHENYL CYCLOPROPANE CARBOXAMIDE

#62
20130197095
2013-08-01

Substituted 4-aminocyclohexane derivatives

#63
20130129758
2013-05-23

Cationic amphiphiles with mannose-mimicking head-groups and a process for the preparation thereof

#64
20130123618
2013-05-16

Imaging Agents

#65
20130090386
2013-04-11

Lysine specific demethylase-1 inhibitors and their use

#66
20130053412
2013-02-28

Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use

#67
20130045978
2013-02-21

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#68
20130023644
2013-01-24

Beta-amino acids

#69
20130018055
2013-01-17

Aryl-benzocycloalkyl amide derivatives

#70
20130012485
2013-01-10

ORGANIC COMPOUNDS

#71
20120323040
2012-12-20

Process for synthesis of amino-methyl tetralin derivatives

#72
20120289512
2012-11-15

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#73
20120245106
2012-09-27

Modified lysine-mimetic compounds

#74
20120238763
2012-09-20

Process for producing 3-alkoxy-2-amino-6-fluorobicyclo [3.1.0] hexane-2,6-dicarboxylic acid derivative and intermediate thereof

#75
20120202810
2012-08-09

Substituted 4-aminocyclohexane derivatives

#76
20120184774
2012-07-19

PROCESS FOR THE PREPARATION OF PHARMACEUTICALLY ACCEPTABLE SALTS OF RACEMIC MILNACIPRAN AND ITS OPTICAL ENANTIOMERS THEREOF

#77
20120142695
2012-06-07

Compounds as bradykinin B1 antagonists

#78
20120101070
2012-04-26

11a, 12-derivatives of tetracycline compounds

#79
20120029013
2012-02-02

Derivatives of aminocyclobutane or aminocyclobutene, their method of preparation and their use as medical products

#80
20120021530
2012-01-26

Heterogeneous foldamers containing α, β, and/or γ-amino acids

#81
20120004227
2012-01-05

Cyclohexane derivative having NPY Y5 receptor antagonism

#82
20110312964
2011-12-22

Cysteine protease inhibitors

#83
20110263626
2011-10-27

Bradykinin B1-antagonists

#84
20110218214
2011-09-08

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#85
20110195979
2011-08-11

COMPOUNDS FOR THE TREATMENT AND PREVENTION OF INFLUENZA

#86
20110144210
2011-06-16

Stable dosage forms of levomilnacipran

#87
20110118440
2011-05-19

Gamma amino acid building blocks

#88
20110112197
2011-05-12

Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide

#89
20110104162
2011-05-05

Compounds which can be used for the treatment of cancers

#90
20110039714
2011-02-17

Probes, Systems, and Methods for Drug Discovery

#91
20110033382
2011-02-10

Imaging Agents

#92
20100317582
2010-12-16

Cyclic hydrocarbon compounds for the treatment of diseases

#93
20100298164
2010-11-25

STRUCTURE-BASED APPROACH TO DESIGN OF INHIBITORS OF PROTEIN-PROCESSIVITY FACTOR INTERACTIONS

#94
20100286353
2010-11-11

ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF

#95
20100274050
2010-10-28

SOLID MILNACIPRAN AND PROCESS FOR THE PREPARATION OF THE SAME

#96
20100249206
2010-09-30

Modified lysine-mimetic compounds

#97
20100240669
2010-09-23

NEW COMPOUNDS

#98
20100168243
2010-07-01

Renin Inhibitors

#99
20100160682
2010-06-24

Process for synthesis of amino-methyl tetralin derivatives

#100
20100145099
2010-06-10

NOVEL POLYMORPHIC FORMS OF MILNACIPRAN HYDROCHLORIDE

#101
20100130737
2010-05-27

Regulating Agent of GPR34 Receptor Function

#102
20100093733
2010-04-15

AMIDE AND UREA DERIVATIVES FOR THE TREATMENT OF METABOLIC DISEASES

#103
20100048572
2010-02-25

Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof

#104
20100016636
2010-01-21

Process for preparing optical pure milnacipran and its pharmaceutically accepted salts

#105
20090291988
2009-11-26

Reversible Inhibitors of Monoamine Oxidase A and B

#106
20090291945
2009-11-26

CYSTEINE PROTEASE INHIBITORS

#107
20090270394
2009-10-29

CYCLYLAMINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS

#108
20090264469
2009-10-22

NOVEL DICARBOXYLIC ACID DERIVATIVES

#109
20090253703
2009-10-08

δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides

#110
20090253701
2009-10-08

δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amide compound

#111
20090247530
2009-10-01

SUBSTITUTED 4-AMINOCYCLOHEXANE DERIVATIVES

#112
20090209787
2009-08-20

Method of preparing chiral cyclic β-aminocarboxamides

#113
20090192198
2009-07-30

INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME

#114
20090176783
2009-07-09

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#115
20090156805
2009-06-18

Cycloalkane carboxamide derivatives and production process of same

#116
20090131434
2009-05-21

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme

#117
20090105257
2009-04-23

Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to GPR40

#118
20090093483
2009-04-09

Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof

#119
20090062287
2009-03-05

Substituted biaryl compounds as factor XIa inhibitors

#120
20080312470
2008-12-18

Mono, di and tri cyclic compounds useful for lowering IgE concentrations

#121
20080275112
2008-11-06

Invention Concerning Aminoadamantane Compounds

#122
20080262230
2008-10-23

Benzyloxypropylamine derivative

#123
20080249130
2008-10-09

Gut microsomal triglyceride transport protein inhibitors

#124
20080242671
2008-10-02

INHIBITORS OF CATHEPSIN S

#125
20080227823
2008-09-18

AMIDE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS

#126
20080125491
2008-05-29

Human G protein-coupled receptor and modulators thereof for the treatment of cell death-related disorders

#127
20080103176
2008-05-01

Substituted Hydroxyethylamines

#128
20080051604
2008-02-28

Process for producing (Z)-1-phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane hydrochloride

#129
20070299080
2007-12-27

Benzamide derivatives and uses related thereto

#130
20070179186
2007-08-02

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#131
20070155743
2007-07-05

Amino alcohol derivatives and their activity as renin inhibitors

#132
20070155671
2007-07-05

Diaminopropionic acid derivatives

#133
20070149569
2007-06-28

Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors

#134
20070149460
2007-06-28

Modified lysine-mimetic compounds

#135
20070142663
2007-06-21

T-butyl cascade polymers

#136
20070135498
2007-06-14

Organic compounds

#137
20070134729
2007-06-14

Novel antibacterial agents

#138
20070123709
2007-05-31

Beta-amino acids

#139
20070117797
2007-05-24

Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity

#140
20070105941
2007-05-10

Substituted cyclohexylcarboxylic acid amide compounds

#141
20070066688
2007-03-22

Cyclopentyl derivatives

#142
20070055459
2007-03-08

Structure-based approach to design of protein-processivity factor interactions

#143
20070049596
2007-03-01

Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)

#144
20070032484
2007-02-08

Cathepsin K inhibitors

#145
20060281773
2006-12-14

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#146
20060281717
2006-12-14

11a, 12-derivatives of tetracycline compounds

#147
20060235081
2006-10-19

Mono di & tri cyclic compounds useful for lowering IgE concentrations

#148
20060223853
2006-10-05

Substituted heterocyclic compounds for treating multidrug resistance

#149
20060183791
2006-08-17

Substituted p-diaminobenzene derivatives

#150
20060154915
2006-07-13

Substituted biaryl compounds as factor XIa inhibitors

#151
20060149070
2006-07-06

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#152
20060135502
2006-06-22

Cyclic derivatives as modulators of chemokine receptor activity

#153
20060128765
2006-06-15

2-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation

#154
20060116421
2006-06-01

Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity

#155
20060069261
2006-03-30

Alkynyl compounds as non nucleoside reverse transcriptase inhibitors

#156
20060041014
2006-02-23

Treatment of male sexual dysfunction

#157
20050277592
2005-12-15

β-peptides

#158
20050245534
2005-11-03

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme

#159
20050239828
2005-10-27

Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists

#160
20050124683
2005-06-09

HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis

#161
20050101744
2005-05-12

T-butyl cascade polymers

#162
20050085667
2005-04-21

N-biphenylmethyl aminocycloalkanecarboxamide derivatives

#163
20050080119
2005-04-14

Diaminopropionic acid derivatives